287 related articles for article (PubMed ID: 36260281)
1. Investigation of the immune escape mechanism of Treponema pallidum.
Tang Y; Zhou Y; He B; Cao T; Zhou X; Ning L; Chen E; Li Y; Xie X; Peng B; Hu Y; Liu S
Infection; 2023 Apr; 51(2):305-321. PubMed ID: 36260281
[TBL] [Abstract][Full Text] [Related]
2. Structural Modeling of the Treponema pallidum Outer Membrane Protein Repertoire: a Road Map for Deconvolution of Syphilis Pathogenesis and Development of a Syphilis Vaccine.
Hawley KL; Montezuma-Rusca JM; Delgado KN; Singh N; Uversky VN; Caimano MJ; Radolf JD; Luthra A
J Bacteriol; 2021 Jul; 203(15):e0008221. PubMed ID: 33972353
[TBL] [Abstract][Full Text] [Related]
3. Two Potential Syphilis Vaccine Candidates Inhibit Dissemination of
Xu M; Xie Y; Zheng K; Luo H; Tan M; Zhao F; Zeng T; Wu Y
Front Immunol; 2021; 12():759474. PubMed ID: 34899710
[TBL] [Abstract][Full Text] [Related]
4. Biological basis for syphilis.
Lafond RE; Lukehart SA
Clin Microbiol Rev; 2006 Jan; 19(1):29-49. PubMed ID: 16418521
[TBL] [Abstract][Full Text] [Related]
5. An In Silico Identification of Common Putative Vaccine Candidates against Treponema pallidum: A Reverse Vaccinology and Subtractive Genomics Based Approach.
Kumar Jaiswal A; Tiwari S; Jamal SB; Barh D; Azevedo V; Soares SC
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216574
[TBL] [Abstract][Full Text] [Related]
6. Insight into the invasion process and immune-protective evaluation of Tp0971, a membrane lipoprotein from
Zhang X; Duan J; Wang Y; Xie B; Zhou J; Zhao S; Yin W; Liu P; Zhao F
Microbiol Spectr; 2023 Dec; 11(6):e0004723. PubMed ID: 37855609
[TBL] [Abstract][Full Text] [Related]
7. Investigation of syphilis immunology and Treponema pallidum subsp. pallidum biology to improve clinical management and design a broadly protective vaccine: study protocol.
Osias E; Hung P; Giacani L; Stafylis C; Konda KA; Vargas SK; Reyes-Díaz EM; Comulada WS; Haake DA; Haynes AM; Caceres CF; Klausner JD
BMC Infect Dis; 2020 Jun; 20(1):444. PubMed ID: 32576149
[TBL] [Abstract][Full Text] [Related]
8. A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum.
Lithgow KV; Hof R; Wetherell C; Phillips D; Houston S; Cameron CE
Nat Commun; 2017 Feb; 8():14273. PubMed ID: 28145405
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional and immunological analysis of the putative outer membrane protein and vaccine candidate TprL of Treponema pallidum.
Haynes AM; Fernandez M; Romeis E; Mitjà O; Konda KA; Vargas SK; Eguiluz M; Caceres CF; Klausner JD; Giacani L
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008812. PubMed ID: 33497377
[TBL] [Abstract][Full Text] [Related]
10. Notes on syphilis vaccine development.
Kojima N; Konda KA; Klausner JD
Front Immunol; 2022; 13():952284. PubMed ID: 35967432
[TBL] [Abstract][Full Text] [Related]
11. Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates.
Parveen N; Fernandez MC; Haynes AM; Zhang RL; Godornes BC; Centurion-Lara A; Giacani L
Vaccine; 2019 Mar; 37(13):1807-1818. PubMed ID: 30797635
[TBL] [Abstract][Full Text] [Related]
12. Estimation of Full-Length TprK Diversity in Treponema pallidum subsp.
Addetia A; Lin MJ; Phung Q; Xie H; Huang ML; Ciccarese G; Dal Conte I; Cusini M; Drago F; Giacani L; Greninger AL
mBio; 2020 Oct; 11(5):. PubMed ID: 33109767
[TBL] [Abstract][Full Text] [Related]
13. Polypeptides of Treponema pallidum: progress toward understanding their structural, functional, and immunologic roles. Treponema Pallidum Polypeptide Research Group.
Norris SJ
Microbiol Rev; 1993 Sep; 57(3):750-79. PubMed ID: 8246847
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits.
Zhao F; Zhang X; Liu S; Zeng T; Yu J; Gu W; Zhang Y; Chen X; Wu Y
Sci China Life Sci; 2013 Feb; 56(2):174-80. PubMed ID: 23334700
[TBL] [Abstract][Full Text] [Related]
15. Treponema pallidum outer membrane proteins: current status and prospects.
Chen J; Huang J; Liu Z; Xie Y
Pathog Dis; 2022 Sep; 80(1):. PubMed ID: 35869970
[TBL] [Abstract][Full Text] [Related]
16. Long-Term
Edmondson DG; Hu B; Norris SJ
mBio; 2018 Jun; 9(3):. PubMed ID: 29946052
[TBL] [Abstract][Full Text] [Related]
17. Progress towards an effective syphilis vaccine: the past, present and future.
Cullen PA; Cameron CE
Expert Rev Vaccines; 2006 Feb; 5(1):67-80. PubMed ID: 16451109
[TBL] [Abstract][Full Text] [Related]
18. Syphilis vaccine: challenges, controversies and opportunities.
Ávila-Nieto C; Pedreño-López N; Mitjà O; Clotet B; Blanco J; Carrillo J
Front Immunol; 2023; 14():1126170. PubMed ID: 37090699
[TBL] [Abstract][Full Text] [Related]
19. Assessment of cell-surface exposure and vaccinogenic potentials of Treponema pallidum candidate outer membrane proteins.
Tomson FL; Conley PG; Norgard MV; Hagman KE
Microbes Infect; 2007 Sep; 9(11):1267-75. PubMed ID: 17890130
[TBL] [Abstract][Full Text] [Related]
20. Current status of syphilis vaccine development: need, challenges, prospects.
Cameron CE; Lukehart SA
Vaccine; 2014 Mar; 32(14):1602-9. PubMed ID: 24135571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
